NERVE GROWTH FACTOR ACTION ENHANCER INCLUDING 1,2-ETHANE DIOL DERIVATIVE OR SALT THEREOF

PROBLEM TO BE SOLVED: To obtain a therapeutic agent for diseases caused by the degeneration of central nervous system. SOLUTION: 1,2-Ethane diol derivatives represented by the general formula (wherein individual signs have the same meanings as described in the specification) or their salts have the...

Full description

Saved in:
Bibliographic Details
Main Authors NARITA HIROKAZU, MAEKAWA MUTSUKO, ONO SATORU, HIRATA KAZUNARI
Format Patent
LanguageEnglish
Published 06.02.2002
Edition7
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To obtain a therapeutic agent for diseases caused by the degeneration of central nervous system. SOLUTION: 1,2-Ethane diol derivatives represented by the general formula (wherein individual signs have the same meanings as described in the specification) or their salts have the effect of enhancing the NGF action and are useful as a therapeutic agent for a variety of diseases caused by the degeneration of central nervous system, for example, senile dementia of Alzheimer type, Huntington's chorea, and the like.
Bibliography:Application Number: JP20010164799